SG11201707308XA - Method for obtaining peptide fragment from antibody by protease decomposition reaction with restrictedreaction field - Google Patents
Method for obtaining peptide fragment from antibody by protease decomposition reaction with restrictedreaction fieldInfo
- Publication number
- SG11201707308XA SG11201707308XA SG11201707308XA SG11201707308XA SG11201707308XA SG 11201707308X A SG11201707308X A SG 11201707308XA SG 11201707308X A SG11201707308X A SG 11201707308XA SG 11201707308X A SG11201707308X A SG 11201707308XA SG 11201707308X A SG11201707308X A SG 11201707308XA
- Authority
- SG
- Singapore
- Prior art keywords
- restrictedreaction
- antibody
- field
- decomposition reaction
- peptide fragment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21004—Trypsin (3.4.21.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015047740 | 2015-03-10 | ||
PCT/JP2015/085458 WO2016143226A1 (en) | 2015-03-10 | 2015-12-18 | Method for obtaining peptide fragment from antibody by means of protease decomposition reaction with restricted reaction field |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201707308XA true SG11201707308XA (en) | 2017-10-30 |
Family
ID=56879451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201707308XA SG11201707308XA (en) | 2015-03-10 | 2015-12-18 | Method for obtaining peptide fragment from antibody by protease decomposition reaction with restrictedreaction field |
Country Status (8)
Country | Link |
---|---|
US (1) | US20180051053A1 (en) |
EP (1) | EP3269821A4 (en) |
JP (1) | JPWO2016143226A1 (en) |
KR (1) | KR20170120697A (en) |
CN (1) | CN107406868A (en) |
CA (1) | CA2979185A1 (en) |
SG (1) | SG11201707308XA (en) |
WO (1) | WO2016143226A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6835260B2 (en) | 2017-12-28 | 2021-02-24 | 株式会社島津製作所 | Simplified quantification method for monoclonal antibodies |
CN111512152B (en) * | 2017-12-28 | 2023-08-11 | 株式会社岛津制作所 | Method for improving detection result of monoclonal antibody |
WO2022270126A1 (en) | 2021-06-23 | 2022-12-29 | 株式会社島津製作所 | Method for analyzing antibody |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007012361A (en) * | 2005-04-07 | 2008-02-11 | Cleveland Clinic Foundation | Gammaretrovirus associated with cancer. |
JP2010195720A (en) * | 2009-02-26 | 2010-09-09 | Yoshihiro Futamura | Tripeptide having osteocyte proliferating action and method for producing the same |
JP2010246424A (en) * | 2009-04-13 | 2010-11-04 | Yukio Takii | Method for diagnosing onset risk of osteoporosis, osteogenesis imperfecta or osteogenesis imperfecta |
CN101962596A (en) * | 2010-09-17 | 2011-02-02 | 昆明理工大学 | Method for synchronously preparing walnut oil and walnut peptide |
CN102516418B (en) * | 2011-12-13 | 2013-09-04 | 中国化工橡胶株洲研究设计院 | Method for mixing natural rubber by wet process |
JP6510747B2 (en) * | 2013-08-02 | 2019-05-08 | 東洋ビーネット株式会社 | Protease activity measurement method |
-
2015
- 2015-12-18 EP EP15884710.3A patent/EP3269821A4/en not_active Withdrawn
- 2015-12-18 SG SG11201707308XA patent/SG11201707308XA/en unknown
- 2015-12-18 US US15/556,812 patent/US20180051053A1/en not_active Abandoned
- 2015-12-18 CA CA2979185A patent/CA2979185A1/en not_active Abandoned
- 2015-12-18 JP JP2017504579A patent/JPWO2016143226A1/en active Pending
- 2015-12-18 WO PCT/JP2015/085458 patent/WO2016143226A1/en active Application Filing
- 2015-12-18 KR KR1020177027612A patent/KR20170120697A/en not_active Application Discontinuation
- 2015-12-18 CN CN201580077609.1A patent/CN107406868A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3269821A4 (en) | 2018-12-05 |
EP3269821A1 (en) | 2018-01-17 |
CA2979185A1 (en) | 2016-09-15 |
CN107406868A (en) | 2017-11-28 |
US20180051053A1 (en) | 2018-02-22 |
KR20170120697A (en) | 2017-10-31 |
JPWO2016143226A1 (en) | 2018-02-22 |
WO2016143226A1 (en) | 2016-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288649A (en) | Humanized anti-tau antibodies | |
IL285366A (en) | Multispecific antigen-binding proteins | |
ZA201803874B (en) | Humanized anti-cd73 antibodies | |
IL264631A (en) | Methods for quantitating individual antibodies from a mixture | |
DK3266792T3 (en) | Method for peptide synthesis | |
HK1258375A1 (en) | Humanized anti-cll-1 antibodies | |
EP3294766C0 (en) | Humanized antibody or fragment thereof specific for cd3 | |
SG11201707318PA (en) | Method for detecting monoclonal antibody using mass spectrometry | |
IL256579A (en) | Humanized antibodies | |
IL259793A (en) | Slc45a2 peptides for immunotherapy | |
SG11201607851PA (en) | Method for analyzing mixture components | |
IL265016B (en) | Methods for purifying antibodies | |
HUP1400114A2 (en) | Method for the production of peptides | |
HUE041860T2 (en) | Methods for improving by-products from fermentation processes using xylanase | |
HK1250046A1 (en) | Anti-dkk-1-anti-rankl bispecific antibody compounds | |
EP3199540A4 (en) | Method for producing hydrophobic peptide | |
HUE051438T2 (en) | Method for denoxing waste gases from nitration | |
PL3371216T3 (en) | Humanized anti-bag3 antibodies | |
IL258981A (en) | Methods for producing proteins | |
SE1530097A1 (en) | Method for Vertical Gate-Last Process | |
SG11201707308XA (en) | Method for obtaining peptide fragment from antibody by protease decomposition reaction with restrictedreaction field | |
GB201622422D0 (en) | Peptide prediction | |
PL3089954T3 (en) | Process for obtaining olefins by metathesis | |
EP3492493A4 (en) | Method for producing antibody fragment | |
IL250288A0 (en) | Misuseability analysis for it infrastructure |